Jiang XS - Search Results

1

Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters.

Jiang XS, Xiao JP, Zhang Y, Xu YJ, Li XP, Chen XJ, Huang XD, Yi JL, Gao L, Li YX. Jiang XS, et al. Radiat Oncol. 2012 Mar 19;7:36. doi: 10.1186/1748-717X-7-36. Radiat Oncol. 2012. PMID: 22429918 Free PMC article. Clinical Trial.

2

Fifty percent patients avoid whole brain radiotherapy: stereotactic radiotherapy for multiple brain metastases: a retrospective analysis of a single center.

Chen X, Xiao J, Li X, Jiang X, Zhang Y, Xu Y, Dai J. Chen X, et al. Clin Transl Oncol. 2012 Aug;14(8):599-605. doi: 10.1007/s12094-012-0849-4. Epub 2012 Jul 19. Clin Transl Oncol. 2012. PMID: 22855144

3

Risk factors of distant brain failure for patients with newly diagnosed brain metastases treated with stereotactic radiotherapy alone.

Chen XJ, Xiao JP, Li XP, Jiang XS, Zhang Y, Xu YJ, Dai JR, Li YX. Chen XJ, et al. Among authors: jiang xs. Radiat Oncol. 2011 Dec 19;6:175. doi: 10.1186/1748-717X-6-175. Radiat Oncol. 2011. PMID: 22182786 Free PMC article.

4

Fractionated stereotactic radiotherapy for 136 patients with locally residual nasopharyngeal carcinoma.

Liu F, Xiao JP, Xu GZ, Gao L, Xu YJ, Zhang Y, Jiang XS, Yi JL, Luo JW, Huang XD, Huan FK, Fang H, Wan B, Li YX. Liu F, et al. Among authors: jiang xs. Radiat Oncol. 2013 Jun 27;8:157. doi: 10.1186/1748-717X-8-157. Radiat Oncol. 2013. PMID: 23806065 Free PMC article. Clinical Trial.

5

Fractionated stereotactic radiotherapy for small-cell lung cancer patients with brain metastases.

Li XP, Xiao JP, Chen XJ, Jiang XS, Zhang Y, Xu YJ. Li XP, et al. Among authors: jiang xs. J Cancer Res Ther. 2014 Jul-Sep;10(3):597-602. doi: 10.4103/0973-1482.137964. J Cancer Res Ther. 2014. PMID: 25313746 Free article.

6

Prognostic effect of symptomatic extracranial lesions on survival of recursive partitioning analysis Class III brain metastatic patients treated with stereotactic radiotherapy.

Chen XJ, Xiao JP, Li XP, Jiang XS, Zhang Y. Chen XJ, et al. Among authors: jiang xs. J Cancer Res Ther. 2016 Jan-Mar;12(1):215-20. doi: 10.4103/0973-1482.160925. J Cancer Res Ther. 2016. PMID: 27072240 Free article.

7

Cetuximab in combination with chemoradiation after induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma: preliminary results.

He X, Xu J, Guo W, Jiang X, Wang X, Zong D. He X, et al. Future Oncol. 2013 Oct;9(10):1459-67. doi: 10.2217/fon.13.151. Future Oncol. 2013. PMID: 24106897

8

Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: An analysis of 614 patients from a single center.

Wu LR, Liu YT, Jiang N, Fan YX, Wen J, Huang SF, Guo WJ, Bian XH, Wang FJ, Li F, Song D, Wu JF, Jiang XS, Liu JY, He X. Wu LR, et al. Among authors: jiang n, jiang xs. Oral Oncol. 2017 Jun;69:26-32. doi: 10.1016/j.oraloncology.2017.03.015. Epub 2017 Apr 7. Oral Oncol. 2017. PMID: 28559017

9

Concurrent chemoradiotherapy with nedaplatin plus paclitaxel or fluorouracil for locoregionally advanced nasopharyngeal carcinoma: Survival and toxicity.

Xu J, He X, Cheng K, Guo W, Bian X, Jiang X, Zhang L, Huang S. Xu J, et al. Head Neck. 2014 Oct;36(10):1474-80. doi: 10.1002/hed.23487. Epub 2014 Feb 1. Head Neck. 2014. PMID: 23996842

10

Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma.

Yin L, Bian XH, Wang X, Chen M, Wu J, Xu JH, Qian PD, Guo WJ, Jiang XS, Zhu HF, Gu JJ, Wu JF, Zhang YW, He X. Yin L, et al. Among authors: jiang xs. PLoS One. 2015 Sep 14;10(9):e0137383. doi: 10.1371/journal.pone.0137383. eCollection 2015. PLoS One. 2015. PMID: 26367317 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters